Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Essen Biotech
M.D. Anderson Cancer Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
TCR2 Therapeutics
University of Pittsburgh
M.D. Anderson Cancer Center
Acepodia Biotech, Inc.
Essen Biotech
BioEclipse Therapeutics
Fate Therapeutics
Fate Therapeutics
BGI, China